Nitrosamine drug contaminants, also called nitrosamine drug impurities, are chemicals known as nitrosamine carcinogenic-risk impurities because they may cause cancer. They can form accidentally through nitrosated reactions during the manufacturing, storage, or breakdown of nitrosamine pharmaceutical products, creating N-nitroso amine transformation products. Some of these, called nitrosamine class 1 impurities, have been found in commonly used medicines and are treated as nitrosamine reportable impurities and nitrosamine controlled impurities. Regulatory authorities check their levels using nitrosamine content categories to keep medicines safe.
Manasa Life Science is a trusted manufacturer and supplier of high-quality nitrosamine and N-nitroso compounds, providing reliable solutions for research, testing, and regulatory compliance. Our assortment includes nitrosamines such as N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), N-Nitrosodi-n-propylamine (NDPA), and N-Nitrosodibutylamine (NDBA), with a comprehensive catalog available on our website. Each compound is meticulously nitrosated and undergoes rigorous quality verification to ensure exceptional purity, consistency, and compliance with international specifications. We also support the study of N-Nitroso amine transformation products and their classification by nitrosamine content categories, enabling accurate monitoring and ensuring product safety.